Drugs Made In America Acquisition II DMII
- Market cap
- $650.4M
- Revenue, 12 months
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|
| SG&A | $59.3K | $38.1K | $155.5K | $235.5K | $132K+123% | $112.2K+195% |
| −$59.3K | −$38.1K | −$155.5K | −$235.5K | −$132K+123% | −$112.2K+195% | |
| Net income | −$59.3K | −$38.1K | −$46.2K | $4.3M | $4.3M | $4.4M |
| $0.00 | $0.00 | $0.00 | $0.30 | $0.32 | $0.32 | |
| 12.5M | 12.5M | 14.4M | 14.5M | 13.7M+10% | 13.7M+10% |
EPS, diluted: 5 periods, Q1 FY25 to Q2 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Drugs Made In America Acquisition II's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| DMIIDrugs Made In America Acquisition II | $650.4M | n/m | 10.8× | n/m | n/m | n/m | |
| PRTHPriority Technology | $652.1M | 11.5× | 14.2× | 0.7× | +9% | 5.6% | |
| FBIZFirst Business Financial Services | $647.7M | 11.4× | 9.4× | n/m | +8% | 31.9% | |
| CARECarter Bankshares | $642.8M | 5.0× | 12.2× | n/m | +78% | 50.5% | |
| VELVelocity Financial | $637.2M | 5.9× | 10.5× | n/m | n/m | n/m | |
| TCBXThird Coast Bancshares | $677.4M | 10.3× | 11.3× | n/m | +26% | 31.4% | |
| GCBCGreene County Bancorp | $623M | 15.2× | 15.0× | n/m | +23% | 44.3% | |
| ACNBAcnb | $682.6M | 12.7× | 12.3× | n/m | n/m | n/m | |
| CASSCass Information Systems | $692.7M | 19.5× | 23.4× | 3.5× | +8% | 18.5% | |
| MSBIMidland States Bancorp | $693.6M | 14.7× | 11.6× | n/m | +0% | 17.4% | |
| BHBBar Harbor Bankshares | $694.6M | 14.0× | 12.4× | n/m | +29% | 25.5% | |
| Peer median | $664.7M | 12.1× | 12.2× | 2.1× | +16% | 28.5% |
More on Drugs Made In America Acquisition II
Each number over time
Its groups
About
- Industry
- Shell Companies
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .